[Administration of low-molecular-weight heparins in obstetrics].
Nikolov
A
A
Kovachev
I
I
Petkov
Iu
Iu
Dimitrov
A
A
D005314:Embryonic and Fetal Development / Q000187:drug effects; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D009774:Obstetrics / Q000639:trends*; D010024:Osteoporosis / Q000209:etiology / Q000517:prevention & control; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D012307:Risk Factors; D013923:Thromboembolism / Q000188:drug therapy* / Q000517:prevention & control; D006475:Vitamin K Deficiency Bleeding / Q000139:chemically induced
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight